Jamie Dlugosch

Jamie Dlugosch

InvestorPlace Writer

Jamie Dlugosch has over 20 years of experience in financial markets including investment banking, equity analysis and research and money management.

Previously, he was the publisher of Al Frank’s Prudent Speculator and CEO of Al Frank Investment Management Inc. He is the founder and editor of The Rational Investor.

Jamie earned his Master’s in Business Administration from the University of North Carolina. He currently lives in Minneapolis with his wife, Sarah, and their two daughters, Julia and Ellie.

Recent Articles

What Does Your Intuition Tell You?

By Jamie Dlugosch, InvestorPlace Writer

Investing in the stock market is really not as complex as many make it out to be. Cut through much of the noise and what you have left is a few basic fundamental principles and intuition.

Top 5 Corporate Bonds for 2009

By Jamie Dlugosch, InvestorPlace Writer

The corporate bond market suffered through one of the worst years in memory in 2008 as the credit markets worldwide collapsed. But from the detritus of the credit and equity markets of the past year, both investment-grade and high-yield corporate debt instruments appear in a strong position to experience a run-up in 2009. Within this sector, I have identified 5 corporate credits as my favorites for the year.

Digital River Prospers in Rough e-Commerce Rapids

By Jamie Dlugosch, InvestorPlace Writer

While the threats for continued growth for DRIV are substantial, the company has been adept at reacting to competitive forces. Management has guided the company to continued increases in market share and profitability.

Monsanto (MON) Outperforms. Agriculture a Safe Haven?

By Jamie Dlugosch, InvestorPlace Writer

Agricultural stocks should be considered a safe haven during economic weakness. Yet agricultural stocks were absolutely pummeled in the latter part of 2008. That being the case, an investment opportunity exists in this sector.

Keep an Eye on Gilead Sciences (GILD)

By Jamie Dlugosch, InvestorPlace Writer

We all know that the major pharmaceutical companies are struggling. Normally, in times of economic distress, shares of the big pharmaceutical companies are seen as a safe haven because of their consistent earnings and dividend payments.

Which Direction Will We Go in 2009?

By Jamie Dlugosch, InvestorPlace Writer

Where we go from here is yet to be determined. There is a very interesting tug of war going on in the market between the bulls and bears, heading into 2009.

5 Stocks for the January Effect

By Jamie Dlugosch, InvestorPlace Writer

There are many theories as to why the theory works, including tax-loss selling at the end of the prior year and genuine enthusiasm for the start of a new year. Whatever the cause, stocks do tend to go up in January in a disproportionate amount. Will there be a January effect this year? I wouldn't bet against it. Here are 5 stocks set to profit from the January effect.

An ‘L’ Shaped Recession. Why it Reeks of Ponzi

By Jamie Dlugosch, InvestorPlace Writer

Will we have a V-shaped recovery quickly bouncing of the lows returning to growth in rapid fashion or will we experience the L-shaped recovery that was the experience of Japan during their lost decade in the 1990's?

Automakers Get Bailed Out – Taxpayers Get Nothing

By Jamie Dlugosch, InvestorPlace Writer

This morning the administration announced that it was lending the industry up to some $17 billion. In return they did achieve some concessions, but they did not go far enough in my opinion.

Take Advantage of Madoff

By Jamie Dlugosch, InvestorPlace Writer

Momentum stocks have taken a hit as the Madoff scandal has inspired liquidation driven by fear and necessity. The good news is that investors can take advantage of this mess by identifying stocks that are undervalued.

Load More